356 related articles for article (PubMed ID: 27197871)
1. Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction.
Kaynak P; Karabulut GO; Ozturker C; Fazil K; Arat YO; Perente I; Akar S; Yilmaz OF; Demirok A
Eye (Lond); 2016 Aug; 30(8):1056-62. PubMed ID: 27197871
[TBL] [Abstract][Full Text] [Related]
2. Results of lacrimal gland botulinum toxin injection for epiphora in lacrimal obstruction and gustatory tearing.
Wojno TH
Ophthalmic Plast Reconstr Surg; 2011; 27(2):119-21. PubMed ID: 21224749
[TBL] [Abstract][Full Text] [Related]
3. Botulinum neurotoxin injection for the treatment of epiphora in nasolacrimal duct obstruction.
Girard B; Piaton JM; Keller P; Abadie C; Nguyen TH
J Fr Ophtalmol; 2017 Oct; 40(8):661-665. PubMed ID: 28847443
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin injection for the treatment of epiphora in lacrimal outflow obstruction.
Ziahosseini K; Al-Abbadi Z; Malhotra R
Eye (Lond); 2015 May; 29(5):656-61. PubMed ID: 25744443
[TBL] [Abstract][Full Text] [Related]
5. Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts.
Girard B; Piaton JM; Keller P; Nguyen TH
J Fr Ophtalmol; 2018 Apr; 41(4):343-349. PubMed ID: 29681465
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin injection into the lacrimal gland for treatment of proximal nasolacrimal duct obstructions in children.
Eustis HS; Babiuch A
J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e75-7. PubMed ID: 25427340
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin for palliative treatment of epiphora in a patient with canalicular obstruction.
Tu AH; Chang EL
Ophthalmology; 2005 Aug; 112(8):1469-71. PubMed ID: 15953639
[TBL] [Abstract][Full Text] [Related]
8. Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial.
Lee AG; Lee SH; Jang M; Lee SJ; Shin HJ
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33494380
[TBL] [Abstract][Full Text] [Related]
9. Management of functional epiphora in patients with an anatomically patent dacryocystorhinostomy.
Shams PN; Chen PG; Wormald PJ; Sloan B; Wilcsek G; McNab A; Selva D
JAMA Ophthalmol; 2014 Sep; 132(9):1127-32. PubMed ID: 24903661
[TBL] [Abstract][Full Text] [Related]
10. Repeated injections of botulinum toxin-A for epiphora in lacrimal drainage disorders: qualitative and quantitative assessment.
Ahn C; Kang S; Sa HS
Eye (Lond); 2019 Jun; 33(6):995-999. PubMed ID: 30765885
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin-B injection into the lacrimal gland and posterior cricoarytenoid muscle for the treatment of epiphora and abductor spasmodic dysphonia secondary to Parkinson's disease.
Sachdev A; Costello D; Madge S
Orbit; 2019 Jun; 38(3):248-251. PubMed ID: 29939826
[TBL] [Abstract][Full Text] [Related]
12. Lacrimal gland botulinum toxin injection for epiphora management.
Jeffers J; Lucarelli K; Akella S; Setabutr P; Wojno TH; Aakalu V
Orbit; 2022 Apr; 41(2):150-161. PubMed ID: 34396904
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic dacryocystorhinostomy as an option for symptomatic epiphora in isolated monocanalicular obstruction.
Mueller AJ; Scofield-Kaplan SM; Tenzel PA; Winward B; Clair BC; Mancini R
Orbit; 2021 Oct; 40(5):419-422. PubMed ID: 32715905
[TBL] [Abstract][Full Text] [Related]
14. Blind canalicular marsupialization in complete punctal absence as part of a systematic approach for classification and treatment of lacrimal system obstructions.
Rumelt S
Plast Reconstr Surg; 2003 Aug; 112(2):396-403. PubMed ID: 12900596
[TBL] [Abstract][Full Text] [Related]
15. A review on use of botulinum toxin for intractable lacrimal drainage disorders.
Singh S; Ali MJ; Paulsen F
Int Ophthalmol; 2018 Oct; 38(5):2233-2238. PubMed ID: 28766277
[TBL] [Abstract][Full Text] [Related]
16. Outcome of External Dacryocystorhinostomy and Monocanalicular Intubation in Patients with Total Obstruction of One Canalicus.
Buttanri IB; Buttanri B; Serin D
Korean J Ophthalmol; 2019 Apr; 33(2):138-141. PubMed ID: 30977323
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of lacrimal gland injection of botulinum toxin in functional versus nonfunctional epiphora.
Singh S; Nair AG; Alam MS; Mukherjee B
Oman J Ophthalmol; 2019; 12(2):104-107. PubMed ID: 31198296
[TBL] [Abstract][Full Text] [Related]
18. Duration of botulinum toxin effect in the treatment of crocodile tears.
Nava-Castañeda A; Tovilla-Canales JL; Boullosa V; Tovilla-y-Pomar JL; Monroy-Serrano MH; Tapia-Guerra V; Garfias Y
Ophthalmic Plast Reconstr Surg; 2006; 22(6):453-6. PubMed ID: 17117101
[TBL] [Abstract][Full Text] [Related]
19. Modified Jones' lacrimal bypass surgery with an angled extended Jones' tube.
Mombaerts I; Colla B
Ophthalmology; 2007 Jul; 114(7):1403-8. PubMed ID: 17289148
[TBL] [Abstract][Full Text] [Related]
20. Letter to the editor regarding the article: "Lacrimal gland botulinum toxin injection for epiphora management".
Anderson C; Swan RT; Hill R
Orbit; 2023 Aug; 42(4):468-469. PubMed ID: 36124825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
